DHRHealth Institute for Research and Development
News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF AKR-001 IN SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)

Study Status:

Active

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The purpose of this study is to evaluate the safety and efficacy of AKR-001 in subjects with NASH.

Information: 

Principal Investigator
Rama Behara, MD
Type of Trial
Prospective/Interventional
© 2023 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram